Can Fite (Israel) Management Performance Evaluation

CANF -- Israel Stock  

ILS 234.30  1.30  0.56%

Analysis of Can Fite manpower and management performance can provide insight into Can Fite stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Can Fite BioPharma future performance. Check also Trending Equities.

Can Fite Management Effectiveness

The company has return on total asset (ROA) of (34.8) % which means that it has lost $34.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (73.21) % meaning that it generated substantial loss on money invested by shareholders.

Can Fite Stakeholders

Pnina Fishman CEO, Director
Ilan Cohen Chairman of the Board
Motti Farbstein CFO, COO
Abraham Sartani Director
Guy Regev Director
Israel Shamay External Director

Can Fite Leadership

Can Fite BioPharma Top Executives

  Pnina Fishman  CEO
CEO, Director
  Ilan Cohen  Chairman
Chairman of the Board

Can Fite Tenure Analysis

Can Fite Employment Tenure

Can Fite employes about 7 people. The company is managed by 6 executives with total tenure of roughly 71 years, averanging almost 11.0 years of service per executive having 1.0 employee per reported executive.

Can FiteManpower Efficiency

Return on Can Fite Manpower

Revenue Per Employee200 K
Revenue Per Executive233.3 K
Net Loss Per Employee707.1 K
Net Loss Per Executive825 K
Check also Trending Equities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.